The Drug Development Core brings together the expertise of the University at Buffalo and Roswell Park Cancer Institute to provide a resource (including training) in preclinical and early clinical development for novel compounds for investigators.
We provide a centralized resource for preclinical pharmacology, pharmacokinetic-pharmacodynamics and early phase clinical trial design, conduct and management.
SUNY Distinguished Professor of Pharmacy Practice
Director, Translational Pharmacology Research Core
UB School of Pharmacy and Pharmaceutical Sciences
Center of Excellence in Bioinformatics and Life Science
Director, UB Center for Integrated Global Biomedical Sciences
Director, Early Phase Clinical Trials Program, Chief of Melanoma
Co-Leader, CCSG Experimental Therapeutics Program
Professor of Oncology, Department of Medicine
Roswell Park Cancer Institute
1. Provide mentoring for faculty and industry in drug development and clinical therapeutics research
2. Provide a centralized core for linking faculty to drug development expertise and CTSI core laboratories